Direct Oral Anticoagulants in Select Patients With Hypercoagulable Disorders.

Published in: The Annals of pharmacotherapy (2020)

The current body of evidence supports the use of select DOACs for the treatment of CAT. In contrast, DOAC use in patients with APS and hereditary thrombophilia should be avoided at this time.

Keyphrases

direct oral anticoagulants
venous thromboembolism
atrial fibrillation
magnetic resonance imaging
computed tomography
combination therapy
contrast enhanced